Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Activism news


From To
PrEP-ing for HIV prevention in Ireland

Lack of access to HIV pre-exposure prophylaxis (PrEP) is presenting dilemmas for the HSE, clinicians, the medicines regulator and those seeking the medication in Ireland. A recent memo to healthcare professionals sent on behalf of the HSE’s Working Group on HIV pre-exposure prophylaxis (PrEP), discouraging them from directing patients to the activist-led website for information on sourcing pre-emptive antiretroviral therapy online, is a talking point among campaigners advocating for access.

18 September 2017
The Medical Independent
Capturing the Wild Sadness of the AIDS Crisis at Its Height

It was not until decades later — after drug advances and cultural changes had dulled the sharp edge of the AIDS crisis, after the disease and those who fought it became something that many people saw as history — that the photographer Stephen Barker realized that he had been creating a photo project about AIDS and the people he met at ACT UP, the AIDS advocacy group.

13 September 2017
Watch: USCA Plenary Halted by Trans Activists

The United States Conference on AIDS (USCA), celebrating thirty years of teaching practical skills to HIV service providers, found itself the target of old-school activism on Friday when transgender activists stopped the plenary program to voice their frustrations about being underrepresented by the organizations in attendance and by the conference itself.

11 September 2017
My Fabulous Disease
5 things you need to know to join the IMPACT trial

The PrEP IMPACT trial is a clinical trial in England and will operate differently to the ways you usually get sexual health services. You'll need to meet eligibility criteria to go on the trial, and you'll need to read and sign paperwork before you start. You'll also be asked to visit your trial clinic every 3 months for HIV and STI tests. The PrEP IMPACT trial starts in September 2017 – and there are 5 important sets of things you need to know if you’re thinking about joining the trial.

07 September 2017
Did HIV Pharma “Pay to Delay” Generic Truvada?

AIDS activists urge the N.Y. attorney general to investigate possible antitrust violations regarding the HIV med used as PrEP.

04 September 2017
AIDS activists urge N.Y. attorney general to probe Gilead for antitrust violations

A group of prominent AIDS activists is urging the New York attorney general to investigate Gilead Sciences (GILD) for potential antitrust violations in connection with deals the drug maker struck with rivals that sought to sell generic versions of a best-selling HIV treatment.

30 August 2017
Obituary: Prudence Mabele

“She was an incredibly articulate, authentic, and real voice demonstrating the struggles and needs of many people, particularly women living with HIV and affected by gender-based violence”, Shaun Mellors said. “For many of us, she was the activist that we aimed to become.”

22 August 2017
The Lancet (free registration required)
France’s next PrEP study aims to assess the wider impact of PrEP on the HIV epidemic

France is launching a new study which will enrol 3000 new pre-exposure prophylaxis (PrEP) users over the next three years, Jean-Michel Molina told the 9th International AIDS

28 July 2017
Roger Pebody
HIV fight continues, TAC pledge to Prudence Mabele

Treatment Action Campaign (TAC) activists have pledged to continue the fight against HIV, Aids, and Tuberculosis (TB) in honour of activist Prudence Mabele and researcher Mark Wainberg.

24 July 2017
Independent Online
Prudence Mabele, leading HIV activist, dies

South Africa's leading advocate for people living with HIV and Aids and a respected gender activist, Prudence Nobantu Mabele, has died from pneumonia at the age of 46.

13 July 2017
← First12345...58Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.